BRIEF-Purapharm Corp Says FY Profit May Fall More Than 90%

Reuters Staff

1 Min Read

Jan 24 (Reuters) - Purapharm Corp Ltd:

* ‍EXPECTED THAT GROUP’S PROFIT FOR YEAR WILL DECLINE SIGNIFICANTLY BY MORE THAN 90 PCT AND MAY EVEN RECORD A LOSS

* EXPECTED RESULT DUE TO DECLINE IN SALES OF GROUP’S CHINA CONCENTRATED CHINESE MEDICINE GRANULES ``CCMG’’ SEGMENT Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

BRIEF-Purapharm Corp Says FY Profit May Fall More Than 90% ​

BRIEF-Purapharm Corp Says FY Profit May Fall More Than 90%